Quarterly report pursuant to Section 13 or 15(d)

Transactions Affecting Stockholders' Equity - Schedule of Stock Options Activity (Details)

v3.20.2
Transactions Affecting Stockholders' Equity - Schedule of Stock Options Activity (Details)
$ / shares in Units, $ in Thousands
9 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Stockholders' Equity [Line Items]  
Weighted Average Remaining Contractual Life (in Years) - Ending 1 year 7 months 6 days
Equity Option [Member]  
Stockholders' Equity [Line Items]  
Number of Shares Options Outstanding - Beginning | shares 3,082,000
Number of Shares, Granted | shares 450,000
Number of Shares, Forfeited/expired | shares
Number of Shares Options Outstanding - Ending | shares 3,532,000
Number of Shares Options Vested and Exercisable | shares 2,481,000
Weighted Average Exercise Price Options Outstanding - Beginning | $ / shares $ 1.67
Weighted Average Exercise Price, Granted | $ / shares 2.74
Weighted Average Exercise Price, Forfeited/expired | $ / shares
Weighted Average Exercise Price Options Outstanding - Ending | $ / shares 1.80
Weighted Average Exercise Price, Options Vested and Exercisable | $ / shares $ 1.64
Weighted Average Remaining Contractual Life (in Years) - Beginning 3 years 8 months 12 days
Weighted Average Remaining Contractual Life (in Years) - Granted 6 years 10 months 25 days
Weighted Average Remaining Contractual Life (in Years) - Forfeited/expired 0 years
Weighted Average Remaining Contractual Life (in Years) - Ending 3 years 4 months 24 days
Weighted Average Remaining Contractual Life (in Years) - Options Vested and Exercisable 2 years 9 months 18 days
Total Intrinsic Value - Beginning | $ $ 1,085
Total Intrinsic Value - Granted | $ 409
Total Intrinsic Value - Ending | $ 6,524
Total Intrinsic Value, Options Vested and Exercisable | $ $ 4,985